<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34518333</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>16</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-330X</ISSN><JournalIssue CitedMedium="Internet"><Volume>93</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of neurology, neurosurgery, and psychiatry</Title><ISOAbbreviation>J Neurol Neurosurg Psychiatry</ISOAbbreviation></Journal><ArticleTitle>De novo mutations in <i>SOD1</i> are a cause of ALS.</ArticleTitle><Pagination><StartPage>201</StartPage><EndPage>206</EndPage><MedlinePgn>201-206</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/jnnp-2021-327520</ELocationID><Abstract><AbstractText Label="OBJECTIVE">The only identified cause of amyotrophic lateral sclerosis (ALS) are mutations in a number of genes found in familial cases but also in sporadic cases. De novo mutations occurring in a parental gonadal cell, in the zygote or postzygotic during embryonal development can result in an apparently sporadic/isolated case of ALS later in life. We searched for de novo mutations in <i>SOD1</i> as a cause of ALS.</AbstractText><AbstractText Label="METHODS">We analysed peripheral-blood exome, genome and Sanger sequencing to identify deleterious mutations in <i>SOD1</i> in 4000 ALS patients from Germany, South Korea and Sweden. Parental kinship was confirmed using highly polymorphic microsatellite markers across the genome. Medical genealogical and clinical data were reviewed and compared with the literature.</AbstractText><AbstractText Label="RESULTS">We identified four sporadic ALS cases with de novo mutations in <i>SOD1</i>. They aggregate in hot-spot codons earlier found mutated in familial cases. Their phenotypes match closely what has earlier been reported in familial cases with pathogenic mutations in <i>SOD1</i>. We also encountered familial cases where de novo mutational events in recent generations may have been involved.</AbstractText><AbstractText Label="CONCLUSIONS">De novo mutations are a cause of sporadic ALS and may also be underpinning smaller families with few affected ALS cases. It was not possible to ascertain if the origin of the de novo mutations was parental germline, zygotic or postzygotic during embryonal development. All ALS patients should be offered genetic counselling and genetic screening, the challenges of variant interpretation do not outweigh the potential benefits including earlier confirmed diagnosis and possible bespoken therapy.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>M&#xfc;ller</LastName><ForeName>Kathrin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Oh</LastName><ForeName>Ki-Wook</ForeName><Initials>KW</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hanyang University Seoul Hospital, Seongdong-gu, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cell Therapy Center, College of Medicine, Hanyang University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Nordin</LastName><ForeName>Angelica</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinical Science, Neurosciences, Ume&#xe5; University, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Panthi</LastName><ForeName>Sudhan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Seung Hyun</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hanyang University Seoul Hospital, Seongdong-gu, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cell Therapy Center, College of Medicine, Hanyang University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nordin</LastName><ForeName>Frida</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Clinical Science, Neurosciences, Ume&#xe5; University, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freischmidt</LastName><ForeName>Axel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ludolph</LastName><ForeName>Albert C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ki</LastName><ForeName>Chang Seok</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Genome Research Centre, GC Genome, Yongin, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forsberg</LastName><ForeName>Karin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Clinical Science, Neurosciences, Ume&#xe5; University, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Biosciences, Ume&#xe5; University, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weishaupt</LastName><ForeName>Jochen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department for Neurodegeneration, Universit&#xe4;tsmedizin Mannheim, Mannheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Young-Eun</ForeName><Initials>YE</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Hanyang University College of Medicine, Seoul, Republic of Korea peter.andersen@umu.se juliana.ye.kim@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andersen</LastName><ForeName>Peter Munch</ForeName><Initials>PM</Initials><Identifier Source="ORCID">0000-0003-0094-5429</Identifier><AffiliationInfo><Affiliation>Clinical Science, Neurosciences, Ume&#xe5; University, Ume&#xe5;, Sweden peter.andersen@umu.se juliana.ye.kim@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Neurol Neurosurg Psychiatry</MedlineTA><NlmUniqueID>2985191R</NlmUniqueID><ISSNLinking>0022-3050</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Neurol Neurosurg Psychiatry. 2022 Feb;93(2):118</RefSource><PMID Version="1">34599043</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="N">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005820" MajorTopicYN="N">Genetic Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056910" MajorTopicYN="N" Type="Geographic">Republic of Korea</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013548" MajorTopicYN="N" Type="Geographic">Sweden</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">motor neuron disease</Keyword><Keyword MajorTopicYN="N">neurogenetics</Keyword></KeywordList><CoiStatement>Competing interests: PMA serves on the scientific advisory boards of Biogen, Regeneron and Orphazyme A/S.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>14</Day><Hour>5</Hour><Minute>55</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34518333</ArticleId><ArticleId IdType="pmc">PMC8784989</ArticleId><ArticleId IdType="doi">10.1136/jnnp-2021-327520</ArticleId><ArticleId IdType="pii">jnnp-2021-327520</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ryan M, Heverin M, McLaughlin RL, et al. . Lifetime risk and heritability of amyotrophic lateral sclerosis. JAMA Neurol 2019;76:1367&#x2013;74. 10.1001/jamaneurol.2019.2044</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2019.2044</ArticleId><ArticleId IdType="pmc">PMC6646974</ArticleId><ArticleId IdType="pubmed">31329211</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, et al. . Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;362:59&#x2013;62. 10.1038/362059a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Al-Chalabi A. Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat Rev Neurol 2011;7:603&#x2013;15. 10.1038/nrneurol.2011.150</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.150</ArticleId><ArticleId IdType="pubmed">21989245</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz JS, Katzberg HD, Woolley SC, et al. . Combined fulminant frontotemporal dementia and amyotrophic lateral sclerosis associated with an I113T SOD1 mutation. Amyotroph Lateral Scler 2012;13:567&#x2013;9. 10.3109/17482968.2012.678365</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.678365</ArticleId><ArticleId IdType="pubmed">22670877</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Nilsson P, Ala-Hurula V, et al. . Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase. Nat Genet 1995;10:61&#x2013;6. 10.1038/ng0595-61</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng0595-61</ArticleId><ArticleId IdType="pubmed">7647793</ArticleId></ArticleIdList></Reference><Reference><Citation>Hand CK, Mayeux-Portas V, Khoris J, et al. . Compound heterozygous D90A and D96N SOD1 mutations in a recessive amyotrophic lateral sclerosis family. Ann Neurol 2001;49:267&#x2013;71. 10.1002/1531-8249(20010201)49:2&amp;lt;267::AID-ANA51&amp;gt;3.0.CO;2-D</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1531-8249(20010201)49:2&amp;lt;267::AID-ANA51&amp;gt;3.0.CO;2-D</ArticleId><ArticleId IdType="pubmed">11220750</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsberg K, Jonsson PA, Andersen PM, et al. . Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients. PLoS One 2010;5:e11552. 10.1371/journal.pone.0011552</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0011552</ArticleId><ArticleId IdType="pmc">PMC2904380</ArticleId><ArticleId IdType="pubmed">20644736</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco DA, Morfini G, Karabacak NM, et al. . Wild-Type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat Neurosci 2010;13:1396&#x2013;403. 10.1038/nn.2660</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2660</ArticleId><ArticleId IdType="pmc">PMC2967729</ArticleId><ArticleId IdType="pubmed">20953194</ArticleId></ArticleIdList></Reference><Reference><Citation>Par&#xe9; B, Lehmann M, Beaudin M, et al. . Misfolded SOD1 pathology in sporadic amyotrophic lateral sclerosis. Sci Rep 2018;8:14223. 10.1038/s41598-018-31773-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-31773-z</ArticleId><ArticleId IdType="pmc">PMC6155098</ArticleId><ArticleId IdType="pubmed">30242181</ArticleId></ArticleIdList></Reference><Reference><Citation>Armon C. Accrued somatic mutations (nucleic acid changes) trigger ALS: 2005-2015 update. Muscle Nerve 2016;53:842&#x2013;9. 10.1002/mus.25049</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.25049</ArticleId><ArticleId IdType="pubmed">26799358</ArticleId></ArticleIdList></Reference><Reference><Citation>Keskin I, Birve A, Berdynski M, et al. . Comprehensive analysis to explain reduced or increased SOD1 enzymatic activity in ALS patients and their relatives. Amyotroph Lateral Scler Frontotemporal Degener 2017;18:457&#x2013;63. 10.1080/21678421.2017.1301481</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1301481</ArticleId><ArticleId IdType="pubmed">28325066</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards S, Aziz N, Bale S, et al. . Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of medical genetics and genomics and the association for molecular pathology. Genet Med 2015;17:405&#x2013;23. 10.1038/gim.2015.30</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gim.2015.30</ArticleId><ArticleId IdType="pmc">PMC4544753</ArticleId><ArticleId IdType="pubmed">25741868</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Borasio GD, Dengler R, et al. . EFNS Task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives. Eur J Neurol 2005;12:921&#x2013;38. 10.1111/j.1468-1331.2005.01351.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2005.01351.x</ArticleId><ArticleId IdType="pubmed">16324086</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong PC, Pardo CA, Borchelt DR, et al. . An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 1995;14:1105&#x2013;16. 10.1016/0896-6273(95)90259-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(95)90259-7</ArticleId><ArticleId IdType="pubmed">7605627</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Forsgren L, Binzer M, et al. . Autosomal recessive adult-onset amyotrophic lateral sclerosis associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation. A clinical and genealogical study of 36 patients. Brain 1996;119 (Pt 4:1153&#x2013;72. 10.1093/brain/119.4.1153</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/119.4.1153</ArticleId><ArticleId IdType="pubmed">8813280</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Sims KB, Xin WW, et al. . Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes. Amyotroph Lateral Scler Other Motor Neuron Disord 2003;4:62&#x2013;73. 10.1080/14660820310011700</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820310011700</ArticleId><ArticleId IdType="pubmed">14506936</ArticleId></ArticleIdList></Reference><Reference><Citation>Morita M, Abe K, Takahashi M, et al. . A novel mutation Asp90Val in the SOD1 gene associated with Japanese familial ALS. Eur J Neurol 1998;5:389&#x2013;92. 10.1046/j.1468-1331.1998.540389.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1468-1331.1998.540389.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones CT, Shaw PJ, Chari G, et al. . Identification of a novel exon 4 SOD1 mutation in a sporadic amyotrophic lateral sclerosis patient. Mol Cell Probes 1994;8:329&#x2013;30. 10.1006/mcpr.1994.1046</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/mcpr.1994.1046</ArticleId><ArticleId IdType="pubmed">7870076</ArticleId></ArticleIdList></Reference><Reference><Citation>Orrell RW, Habgood JJ, Malaspina A, et al. . Clinical characteristics of SOD1 gene mutations in UK families with ALS. J Neurol Sci 1999;169:56&#x2013;60. 10.1016/S0022-510X(99)00216-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(99)00216-6</ArticleId><ArticleId IdType="pubmed">10540008</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers J, Lelie H, Workman A, et al. . Distinctive features of the D101N and D101G variants of superoxide dismutase 1; two mutations that produce rapidly progressing motor neuron disease. J Neurochem 2014;128:305&#x2013;14. 10.1111/jnc.12451</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.12451</ArticleId><ArticleId IdType="pmc">PMC3971632</ArticleId><ArticleId IdType="pubmed">24032979</ArticleId></ArticleIdList></Reference><Reference><Citation>Wroe R, Wai-Ling Butler A, Andersen PM, et al. . ALSOD: the amyotrophic lateral sclerosis online database. Amyotroph Lateral Scler 2008;9:249&#x2013;50. 10.1080/17482960802146106</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960802146106</ArticleId><ArticleId IdType="pubmed">18608099</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM. Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene. Curr Neurol Neurosci Rep 2006;6:37&#x2013;46. 10.1007/s11910-996-0008-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-996-0008-9</ArticleId><ArticleId IdType="pubmed">16469270</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekhtiari Bidhendi E, Bergh J, Zetterstr&#xf6;m P, et al. . Mutant superoxide dismutase aggregates from human spinal cord transmit amyotrophic lateral sclerosis. Acta Neuropathol 2018;136:939&#x2013;53. 10.1007/s00401-018-1915-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1915-y</ArticleId><ArticleId IdType="pmc">PMC6280858</ArticleId><ArticleId IdType="pubmed">30284034</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinman L, Liu HN, Sato C, et al. . A mechanism for low penetrance in an ALS family with a novel SOD1 deletion. Neurology 2009;72:1153&#x2013;9. 10.1212/01.wnl.0000345363.65799.35</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000345363.65799.35</ArticleId><ArticleId IdType="pmc">PMC2680064</ArticleId><ArticleId IdType="pubmed">19332692</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandelin E, Nordlund A, Andersen PM, et al. . Amyotrophic lateral sclerosis-associated copper/zinc superoxide dismutase mutations preferentially reduce the repulsive charge of the proteins. J Biol Chem 2007;282:21230&#x2013;6. 10.1074/jbc.M700765200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M700765200</ArticleId><ArticleId IdType="pubmed">17513298</ArticleId></ArticleIdList></Reference><Reference><Citation>Bidhendi EE, Bergh J, Zetterstr&#xf6;m P, et al. . Two superoxide dismutase prion strains transmit amyotrophic lateral sclerosis-like disease. J Clin Invest 2016;126:2249&#x2013;53. 10.1172/JCI84360</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI84360</ArticleId><ArticleId IdType="pmc">PMC4887173</ArticleId><ArticleId IdType="pubmed">27140399</ArticleId></ArticleIdList></Reference><Reference><Citation>Cudkowicz ME, McKenna-Yasek D, Sapp PE, et al. . Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann Neurol 1997;41:210&#x2013;21. 10.1002/ana.410410212</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410410212</ArticleId><ArticleId IdType="pubmed">9029070</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezania K, Yan J, Dellefave L, et al. . A rare Cu/Zn superoxide dismutase mutation causing familial amyotrophic lateral sclerosis with variable age of onset, incomplete penetrance and a sensory neuropathy. Amyotroph Lateral Scler Other Motor Neuron Disord 2003;4:162&#x2013;6. 10.1080/aml.4.3.162.166</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/aml.4.3.162.166</ArticleId><ArticleId IdType="pubmed">13129803</ArticleId></ArticleIdList></Reference><Reference><Citation>Holm&#xf8;y T, Wilson JA, von der Lippe C, et al. . G127R: a novel SOD1 mutation associated with rapidly evolving ALS and severe pain syndrome. Amyotroph Lateral Scler 2010;11:478&#x2013;80. 10.3109/17482960903580315</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960903580315</ArticleId><ArticleId IdType="pubmed">20192886</ArticleId></ArticleIdList></Reference><Reference><Citation>Parton MJ, Broom W, Andersen PM, et al. . D90A-SOD1 mediated amyotrophic lateral sclerosis: a single founder for all cases with evidence for a cis-acting disease modifier in the recessive haplotype. Hum Mutat 2002;20:473&#x2013;80. 10.1002/humu.9081</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.9081</ArticleId><ArticleId IdType="pubmed">12442272</ArticleId></ArticleIdList></Reference><Reference><Citation>Broom WJ, Johnson DV, Auwarter KE, et al. . SOD1A4V-mediated ALS: absence of a closely linked modifier gene and origination in Asia. Neurosci Lett 2008;430:241&#x2013;5. 10.1016/j.neulet.2007.11.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2007.11.004</ArticleId><ArticleId IdType="pubmed">18055113</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcia P, Camu W, Brulard C, et al. . Effect of familial clustering in the genetic screening of 235 French ALS families. J Neurol Neurosurg Psychiatry 2021;92:479&#x2013;84. 10.1136/jnnp-2020-325064</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-325064</ArticleId><ArticleId IdType="pubmed">33408239</ArticleId></ArticleIdList></Reference><Reference><Citation>Yulug IG, Katsanis N, de Belleroche J, et al. . An improved protocol for the analysis of SOD1 gene mutations, and a new mutation in exon 4. Hum Mol Genet 1995;4:1101&#x2013;4. 10.1093/hmg/4.6.1101</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/4.6.1101</ArticleId><ArticleId IdType="pubmed">7655468</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander MD, Traynor BJ, Miller N, et al. . "True" sporadic ALS associated with a novel SOD-1 mutation. Ann Neurol 2002;52:680&#x2013;3. 10.1002/ana.10369</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.10369</ArticleId><ArticleId IdType="pubmed">12402272</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y-E, Oh K-W, Kwon M-J, et al. . De novo FUS mutations in 2 Korean patients with sporadic amyotrophic lateral sclerosis. Neurobiol Aging 2015;36:1604.e17&#x2013;1604.e19. 10.1016/j.neurobiolaging.2014.10.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.10.002</ArticleId><ArticleId IdType="pubmed">25457557</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvo A, Moglia C, Canosa A, et al. . A de novo nonsense mutation of the FUS gene in an apparently familial amyotrophic lateral sclerosis case. Neurobiol Aging 2014;35:1513.e7&#x2013;1513.e11. 10.1016/j.neurobiolaging.2013.12.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.12.028</ArticleId><ArticleId IdType="pmc">PMC3961545</ArticleId><ArticleId IdType="pubmed">24439481</ArticleId></ArticleIdList></Reference><Reference><Citation>Waibel S, Neumann M, Rosenbohm A, et al. . Truncating mutations in FUS/TLS give rise to a more aggressive ALS-phenotype than missense mutations: a clinico-genetic study in Germany. Eur J Neurol 2013;20:540&#x2013;6. 10.1111/ene.12031</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.12031</ArticleId><ArticleId IdType="pubmed">23217123</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas G, Veltman JA. The role of de novo mutations in adult-onset neurodegenerative disorders. Acta Neuropathol 2019;137:183&#x2013;207. 10.1007/s00401-018-1939-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1939-3</ArticleId><ArticleId IdType="pmc">PMC6513904</ArticleId><ArticleId IdType="pubmed">30478624</ArticleId></ArticleIdList></Reference><Reference><Citation>Clement AM, Nguyen MD, Roberts EA, et al. . Wild-Type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 2003;302:113&#x2013;7. 10.1126/science.1086071</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1086071</ArticleId><ArticleId IdType="pubmed">14526083</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller T, Cudkowicz M, Shaw PJ, et al. . Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS. N Engl J Med 2020;383:109&#x2013;19. 10.1056/NEJMoa2003715</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2003715</ArticleId><ArticleId IdType="pubmed">32640130</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>